These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 3402355

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
    Amodeo C, Barros LM, Batlouni M, Sousa JE.
    Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
    [Abstract] [Full Text] [Related]

  • 4. Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide.
    Distler A, Haerlin R, Hilgenstock G, Passfall J.
    Drugs; 1990 Aug; 40 Suppl 4():21-7; discussion 28-30. PubMed ID: 2092965
    [Abstract] [Full Text] [Related]

  • 5. Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
    Kaneko Y.
    Drugs; 1988 Aug; 35 Suppl 6():156-63. PubMed ID: 3042355
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E, Heikkilä O, Jääskeläinen T, Lilja M, Jounela AJ.
    Eur J Clin Pharmacol; 1985 Aug; 28(1):35-9. PubMed ID: 3886400
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of urapidil in the management of essential hypertension. A comparison with captopril.
    Rosenthal J, Haerlin R, Schäfer N, Christ B, Wurst W.
    Drugs; 1988 Aug; 35 Suppl 6():147-55. PubMed ID: 3042354
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overview of clinical trials with urapidil.
    Schook CE, Radtke H, Wurst W, Thieme G.
    Am J Cardiol; 1989 Aug 15; 64(7):30D-37D. PubMed ID: 2667312
    [Abstract] [Full Text] [Related]

  • 13. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Aug 15; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B, Gerwe M, Braun M, Funken C.
    Arzneimittelforschung; 2005 Aug 15; 55(9):505-13. PubMed ID: 16229114
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
    Stumpe KO, Feldhaus P, Haerlin R.
    Fortschr Med; 1989 Jan 15; 107(1):54-7. PubMed ID: 2646188
    [Abstract] [Full Text] [Related]

  • 19. Improved orthostatic dysregulation record after administration of a sustained-release form of urapidil.
    Kirsten R, Nelson K, Kirch W, Hutt HJ, Molz KH, Theodor R, Nieder M, Dilger C, Haerlin R, Wurst W.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul 15; 27(7):338-41. PubMed ID: 2777422
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H, Yang HM, Lee HY, Kim JJ, Choi DJ, Seung KB, Jeon ES, Ha JW, Rim SJ, Park JB, Shin JH, Oh BH.
    Clin Ther; 2012 Jun 15; 34(6):1273-89. PubMed ID: 22608107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.